Related Experiment Video
Updated: May 28, 2025

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Dose-Dependent Relationship Between Long-Term Metformin Use and the Risk of Diabetic Retinopathy: A Population-Based
Yu-Ching Li1,2,3, Kuang-Hua Huang1, Yih Yang4
1Department of Health Services Administration, China Medical University, Taichung, Taiwan.
Metformin use in diabetes mellitus patients shows a dual effect on diabetic retinopathy risk. Lower doses may reduce risk, while higher doses significantly increase it, indicating a dose-dependent relationship.
Area of Science:
- Endocrinology
- Ophthalmology
- Pharmacology
Background:
- Concerns exist regarding metformin's association with increased diabetic retinopathy risk.
- The dose-dependent effect of metformin on diabetic retinopathy remains unclear.
Purpose of the Study:
- To investigate the relationship between metformin treatment and diabetic retinopathy risk.
- To determine if metformin affects diabetic retinopathy risk in a dose-dependent manner.
Main Methods:
- Secondary analysis of a nationwide Taiwanese population database (2002-2013).
- Included patients aged 20+ with new-onset type 2 diabetes mellitus.
- Compared metformin users with sulfonylurea users using Cox proportional hazards models, analyzing cumulative defined daily dose and treatment intensity.
Main Results:
- Analysis included 241,231 metformin users and 152,617 sulfonylurea users.
- Lower cumulative metformin dose (<30 DDD) was associated with reduced diabetic retinopathy risk (aHR=0.77).
- Higher metformin doses (>25 DDD) were linked to a significantly increased risk (aHR=2.43) compared to sulfonylureas.
Conclusions:
- Lower cumulative metformin dosage in diabetes mellitus patients is linked to a reduced risk of diabetic retinopathy.
- Higher intensity of metformin use is associated with an elevated risk of diabetic retinopathy.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

